Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000247866 | SCV000313403 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001618461 | SCV001842693 | benign | not provided | 2019-07-11 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278207 | SCV002565178 | benign | Ehlers-Danlos syndrome | 2022-04-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374425 | SCV002688063 | benign | Cardiovascular phenotype | 2018-12-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |